Research Insights on Diabetes Drug and Long COVID Prevention
Long COVID Prevalence
More than one-third of individuals who have contracted COVID-19 experience long COVID, a condition characterized by persistent symptoms lasting at least three months. Common manifestations include extreme fatigue, cognitive difficulties (often referred to as brain fog), respiratory issues, heart palpitations, and musculoskeletal pain.
Health Complications Linked to Long COVID
Long COVID can lead to severe health complications such as postural orthostatic tachycardia syndrome (POTS), stroke, fibromyalgia, anxiety disorders, chronic fatigue syndrome, and chronic kidney disease. Currently, there is no definitive cure for long COVID, and treatment typically involves symptom management through medications, mental health support, and various therapeutic approaches including physical and respiratory therapies.
Prevention Strategies
Given that anyone can develop long COVID, vaccination against COVID-19 is deemed the most effective strategy for prevention. The COVID vaccine significantly reduces the risk of contracting the virus and, consequently, the associated long-term effects.
Potential Role of Metformin
A recent commentary published in the journal Clinical Infectious Diseases highlights the potential benefits of metformin, a widely used diabetes medication. The researchers propose that taking metformin during or shortly after infection with the SARS-CoV-2 virus may help mitigate the risk of developing long COVID.